MX9701294A - Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora. - Google Patents

Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora.

Info

Publication number
MX9701294A
MX9701294A MX9701294A MX9701294A MX9701294A MX 9701294 A MX9701294 A MX 9701294A MX 9701294 A MX9701294 A MX 9701294A MX 9701294 A MX9701294 A MX 9701294A MX 9701294 A MX9701294 A MX 9701294A
Authority
MX
Mexico
Prior art keywords
carnithine
derivative
medicament containing
chronic obliterating
obliterating arteriosclerosis
Prior art date
Application number
MX9701294A
Other languages
English (en)
Other versions
MXPA97001294A (es
Inventor
Marco Corsi
Original Assignee
Sigma Tau Ind Farmaceuti
S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, S P A filed Critical Sigma Tau Ind Farmaceuti
Publication of MX9701294A publication Critical patent/MX9701294A/es
Publication of MXPA97001294A publication Critical patent/MXPA97001294A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe el uso de L-carnitina de propionilo y las sales de esta aceptables en farmacología para producir un medicamento para el tratamiento de la arterioesclerosis cronica obliteradora el cual es selectivamente apropiado para el tratamiento de pacientes con una incapacidad severa de claudicacion intermitente.
MXPA/A/1997/001294A 1996-03-04 1997-02-20 Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora MXPA97001294A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96830093A EP0793962B1 (en) 1996-03-04 1996-03-04 Medicament containing a carnitine derivative for treating arteriosclerosis obliterans
EP96830093 1996-03-04

Publications (2)

Publication Number Publication Date
MX9701294A true MX9701294A (es) 1997-09-30
MXPA97001294A MXPA97001294A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ZA971808B (en) 1998-07-31
US5811457A (en) 1998-09-22
GR3032903T3 (en) 2000-07-31
DE69605531T2 (de) 2000-05-31
EP0793962B1 (en) 1999-12-08
ATE187329T1 (de) 1999-12-15
PT793962E (pt) 2000-05-31
KR100346883B1 (ko) 2003-01-06
KR970064602A (ko) 1997-10-13
DE69605531D1 (de) 2000-01-13
TW349863B (en) 1999-01-11
DK0793962T3 (da) 2000-05-22
EP0793962A1 (en) 1997-09-10
CA2198833C (en) 2003-07-22
ES2141463T3 (es) 2000-03-16
JPH09323927A (ja) 1997-12-16
CA2198833A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
GB9907461D0 (en) Neurite regeneration
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
ITMI940326A0 (it) Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica
CA2176298A1 (en) A single high dose fluoroquinolone treatment
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
AU1117092A (en) Treatment of lower urinary tract disorders
TW349863B (en) Carnitine derivative-containing medicament for treating chronic arteriosclerosis obliterans
EP1440689A3 (en) Treatment of neurotic disorders
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
HUT60438A (en) Application of inhaled non-steroid inflammation reducers for potentiation of antireactive, antiasthmatic effect of inhaled henle's loop-diuretics
ZA200107143B (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
MY110149A (en) Compounds for the treatment of neurodegenerative disorders
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
SE9602262D0 (sv) New use of derivatives of cystine
FR2802101B1 (fr) Association de cymemazine et d'un neuroleptique atypique
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
IT1299069B1 (it) Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")